Results 81 to 90 of about 772,552 (212)

Pilot study of pirinixil (BR 931) in various forms of hyperlipoproteinemias

, 1981
The lipid lowering activity of pirinixil (BR 931), a new agent chemically unrelated to clofibrate, was tested in 12 patients (3 M and 9 F), 6 with predominant plasma cholesterol elevation (types IIA and IIB), and 6 with triglyceride elevation (type IV ...
C. Najemnik, C.R. Sirtori, K. Irsigler
core   +1 more source

Serum apolipoprotein profile of patients with chronic renal failure

, 1987
Serum apolipoprotein profile of patients with chronic renal failure. Serum concentrations of apolipoproteins A-I, A-II, B, C-I, C-II, C-III and E were determined by electroimmunoassay in 56 patients with chronic renal failure (CRF) in the predialytic ...
Alaupovic, Petar, Gustafson, Anders, Attman, Per-Ola   +2 more
core   +1 more source

Multicentre study of soybean protein diet for outpatient hyper-cholesterolaemic patients

, 1980
The animal proteins in a low-lipid, low-cholesterol diet were substituted with a textured soybean preparation for 127 outpatients with stable type II hyperlipoproteinemia selected from 8 Italian and one Swiss lipid clinics.
A. Gaddi, E. Bertelli, U. Senin, C.R. Sirtori, G. Mannino, C. Fragiacomo, G. Noseda, G.C. Descovich, C. Ceredi, E. Mannarino, M. S. Benassi, L. Cattin, G. C. Descovich, C. Caruzzo, M.S. Benassi, M. Sirtori, L. Colombo, G. Fontana   +17 more
core   +1 more source

Peroxisome Proliferator-Activated Receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes

, 2006
Background: PPARs exhibit anti-inflammatory capacities and are potential modulators of the inflammatory response. We hypothesized that their expression and/or function may be altered in cystic fibrosis (CF), a disorder characterized by an excessive host ...
Wagner, Thomas, Reynders, Veerle, Veerle Reynders, Stefan Loitsch, Joachim Bargon, Reynders Veerle, Thomas Wagner, Steinhauer, Constanze, Bargon Joachim, Steinhilber Dieter, Bargon, Joachim, Loitsch Stefan, Dieter Steinhilber, Constanze Steinhauer, Loitsch, Stefan Marcel, Wagner Thomas, Steinhauer Constanze, Steinhilber, Dieter   +17 more
core   +1 more source

Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia

Circulation, 1974
N. Stone, R. Levy, D. Fredrickson, J. Verter   +3 more
semanticscholar   +1 more source

Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood.

Journal of Clinical Investigation, 1974
P. Kwiterovich, D. Fredrickson, R. Levy
semanticscholar   +1 more source

Recent progress in the development of radioimmunoassays for human serum lipoproteins

, 1978
A review of radioimmunoassays for measuring human apolipoprotein B (apo B), the A apolipoproteins of high density lipoprotein (apo A-I and apo A-II) and apolipoprotein C-II (apo C-II) in human plasma and in isolated lipoproteins is presented.
Karlin, J B, Goldberg, R, Rubenstein, A H, Juhn, D J   +3 more
core  

Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia

Arquivos Brasileiros de Cardiologia
Maria Cristina de Oliveira Izar, Francisco Antonio Helfenstein Fonseca   +1 more
doaj   +1 more source

Apolipoprotein E delivery by peritoneal implantation of encapsulated recombinant cells improves the hyperlipidaemic profile in apoE-deficient mice

, 2005
Plasma apolipoprotein E (apoE) is a 34-kDa polymorphic protein which has atheroprotective actions by clearing remnant lipoproteins and sequestering excess cellular cholesterol.
Dickson, G, Owen, JS, Heald, KA, Tagalakis, AD, Graham, IR, Diakonov, IA, Harris, JD, Mulcahy, JV   +7 more
core  

Propofol and Hypertriglyceridemia in the ICU: A Systematic Review and Meta-Analysis of Recent Observational Data. [PDF]

Cureus
Hendrix AN, Kerrison CH, Holley ZC, Makani A, Norris A, Orcutt G, Carlyle LB, Watson C, Prest PJ.   +8 more
europepmc   +1 more source